CLINICAL_TRIALS
trial_result
· 2023-05-03
Clinical Trial Update: A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201) [Phase 2]
Summary
Phase 2 study of INCMGA00012 in metastatic Merkel cell carcinoma has completed, with results posted in May 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Incyte Corporation | Conditions: Metastatic Merkel Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2023-05-03